Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-07-001993
Filing Date
2007-03-30
Accepted
2007-03-30 16:54:32
Documents
6
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 IDERA PHARMACEUTICALS, INC. b63679ipe10vk.htm 10-K 1132274
2 EX-23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM b63679ipexv23w1.htm EX-23.1 1759
3 EX-31.1 SECTION 302 CERTIFICATION OF C.E.O. b63679ipexv31w1.htm EX-31.1 5891
4 EX-31.2 SECTION 302 CERTIFICATION OF C.F.O. b63679ipexv31w2.htm EX-31.2 5916
5 EX-32.1 SECTION 906 CERTIFICATION OF C.E.O. b63679ipexv32w1.htm EX-32.1 3097
6 EX-32.2 SECTION 906 CERTIFICATION OF C.F.O. b63679ipexv32w2.htm EX-32.2 3071
  Complete submission text file 0000950135-07-001993.txt   1153500
Mailing Address 345 VASSAR STREET CAMBRIDGE MA 02139
Business Address 345 VASSAR STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31918 | Film No.: 07733677
SIC: 2836 Biological Products, (No Diagnostic Substances)